Clinical Trial Update: Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior Cruciate Ligament (ACL) Reconstruction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of OMS103HP in autograft anterior cruciate ligament reconstruction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Injury
• Knee Injuries

Drugs mentioned

• OMS103HP

Snippet

Sponsor: Omeros Corporation | Conditions: Knee Injuries | Phase 3 | Status: COMPLETED